Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
39.33
+0.28 (0.72%)
At close: Jul 14, 2025, 4:00 PM
39.23
-0.10 (-0.25%)
After-hours: Jul 14, 2025, 4:00 PM EDT
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $2.28 billion as of July 14, 2025. Its market cap has decreased by -10.27% in one year.
Market Cap
2.28B
Enterprise Value
876.58M
1-Year Change
-10.27%
Ranking
Category
Stock Price
$39.33
Market Cap Chart
Since July 15, 2020, Agios Pharmaceuticals's market cap has decreased from $3.61B to $2.28B, a decrease of -36.88%. That is a compound annual growth rate of -8.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 2.24B | 20.20% |
| Dec 31, 2024 | 1.87B | 49.95% |
| Dec 29, 2023 | 1.24B | -19.09% |
| Dec 30, 2022 | 1.54B | -14.07% |
| Dec 31, 2021 | 1.79B | -40.59% |
| Dec 31, 2020 | 3.01B | -16.50% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |